◊ Pharmacokinetic study of single and multiple drug administration in human body; ◊ Human tolerance to single and multiple administration; ◊ Pharmacokinetic study; ◊ Study on material balance and biotransformation of human body; ◊ Drug interaction research; ◊ Drug interaction research; ◊ human bioequivalence research; ◊ Comparative study of pharmacokinetics.
advantage
◊ Chemical Medicine Research has nearly 20 years of research experience which can provide one-stop work in clinical pharmacology research, including clinical operation, analysis of large or small molecular biological samples, data management and statistics, etc. ◊ We participated in the establishment of bioequivalence test committee of Zhongguancun Jiutai drug clinical trial technology innovation alliance (formerly China GCP alliance) in 2017, which ensured the hospital and expert resources of phase I clinical research and BE. ◊ Chemical Medicine Research has participated in the construction of phase I clinical trial wards in 5 hospitals, and established strategic cooperation on phase I clinical trial with more than 10 authoritative hospitals in China. ◊ We have a biological sample analysis center, and the testing and analysis projects have been verified by the Food and Drug Inspection Center of the National Medical Products Administration. We have strong analytical and development capabilities, and has developed and established more than 100 large and small molecule detection and analysis methods. ◊ Chemical Medicine Research has an in vitro and in vivo data bridging analysis team consisting of pharmaceutical experts, non-clinical research experts and clinical experts to provide decision-making for research risks and solutions for collaborative projects, reduce risks and improve progress. ◊ Relying on the accumulated research experience and expert resources, adopting the concept of one-stop service to reduce the connection and risk between different research parts, thus improving the speed and quality of project research.